Aims: Finasteride inhibits the conversion of testosterone to dihydrotestosterone.
| INTRODUCTION
Androgen plays a pivotal role in the regulation of multiple neuropsychiatric behaviors in the central nervous system. [1] [2] [3] Numerous studies have revealed that disturbance of central androgen contributes to the pathogenesis of neuropsychiatric disorders, such as Tourette syndrome, which usually occurs in the developmental children and characterized by multiple motor tics and vocal tics. 4 For instance, application of androgen aggravated motor tics in Tourette syndrome patients, 5, 6 while treatment with flutamide, an androgen receptor antagonist, significantly alleviated the Tourette syndrome symptoms. 7, 8 Dopaminergic system in the brain also plays an important role in the regulation of behaviors besides its regulation on extra-pyramidal system, and studies have shown that dopaminergic system can be regulated by androgen in the brain. For example, administration of nandrolone decanoate or testosterone significantly enhanced activity of dopaminergic system in adult rats, presented as increased dopamine transporter binding densities in caudate putamen (CPu). 9, 10 Intranasal administration of testosterone facilitated the release of dopamine and increased contents of dopamine in the intercellular space. 11 These studies suggest a possibility that the dopaminergic system might be involved in some androgen disturbance-induced neuropsychiatric diseases. Indeed, aberrant metabolisms of dopamine have been shown to contribute to the development and maintenance of Tourette syndrome. [12] [13] [14] [15] Finasteride is a type II 5α reductase inhibitor and inhibits the conversion of testosterone to dihydrotestosterone which is the potent androgen. 16 Finasteride is mainly used for the treatment of high androgen-induced illness, such as benign prostatic hyperplasia and alopecia. 17 Preliminary study revealed that finasteride treatment to male adult patients with Tourette syndrome could significantly improve symptoms of Tourette syndrome, such as motor and vocal tics, 17, 18 and elicit antipsychotic-like effect in rats. 19 Considering the regulatory effect of androgen on dopaminergic system in the brain, it could be hypothesized that finasteride might inhibit dopaminergic system by inhibiting androgen. Therefore, the present study was undertaken to investigate the effect of finasteride on brain dopaminergic system in adolescent and early developmental rats, including the contents of dopamine and its metabolites, tyrosine hydroxylase expressions at both gene and protein levels. Meanwhile, open-field behaviors were tested because of the regulatory effect of dopaminergic system on the behaviors. This study would facilitate the understanding and clinical application of finasteride in the treatment of neuropsychiatric disorders. 
| MATERIALS AND METHODS

| Animals
Open-field behaviors Descriptions of behaviors
Exploratory behavior
Walking
The number of rats walk around while sniffing the environment [50] [51] [52] Sniffing The number of rats sniff the environment while moving [50] [51] [52] [53] Climbing The number of rats stand up with hind feet leaning against wall [50] [51] [52] Rearing The number of rats stand up without rear feet leaning against wall [50] [51] [52] Motor behavior
Vertical activity The number of rats stand up with hind feet 54, 55 Horizontal activity The number of rats cross the squares [54] [55] [56] [57] Total path length 
| Groupings and protocols
The adolescent rats of postnatal day 35 (n = 28) were randomly divided into control and finasteride group. According to the dose of finasteride used, finasteride group was further divided into 3 subgroups of 3, 25
and 50 mg/kg (n = 7 for each dose). The doses of finasteride were determined based on the previous reports. [20] [21] [22] Figure 1A ). The frontal cortex, hippocampus, CPu and nucleus accumbens (Acb), which are the sites of dopaminergic projections located at, were dissected for the assay of contents of dopamine and its metabolites including dihydroxy phenyl acetic acid (DOPAC) and homovanillic acid (HVA).
The substantia nigra (SN) and ventral tegmental area (VTA), which are the sites of dopaminergic neurons located at, were dissected for the assay of expressions of tyrosine hydroxylase (TH) at both gene and protein levels.
F I G U R E 2 Open-field test shows the effect of finasteride on exploratory behaviors in adolescent (A) and early developmental rats (B). **P < 0.01, *P < 0.05. It is shown that finasteride treatment at doses of 25 and 50 mg/kg significantly inhibits the exploratory behaviors in adolescent rats (A) in comparison with control group, while has no effect in early developmental rats (B).
(n = 7 for each group)
In addition, the effect of finasteride on early developmental rats of postnatal day 7 was also observed as the control of adolescent 
| Open-field test
The The open-field test was conducted according to the previous reports. 23, 24 Briefly, on the test day, each rat was placed at the center of arena and was allowed to explore and videotaped for 15 minutes. Exploratory and motor behaviors (Table 1) were scored by observers blind to the experimental plan.
| Liquid chromatography-mass spectrometry (LC-MS/MS)
Cerebral dopamine and its metabolites including DOPAC and HVA were determined by LC-MS/MS. Tissues including frontal cortex, hippocampus, CPu and Acb were weighed and homogenized in 80% acetonitrile containing 0.1% formic acid (5 μL/mg). The homogenates were centrifuged at 21 100 g and 4°C for 10 minutes. The supernatant was collected and stored at −80°C. The LC separation was carried out on an Agileng 1200 LC system using a PhenomenexKinetex F5 column (100 × 2.1 mm, 2.6 μm). MS/MS detection was conducted on a 3200 QTRAP LC-MS/MS system. The multiple-reaction monitoring mode was used for the quantification.
| Real-Time Quantitative RT-PCR
This method was used for the assay of TH gene expression in SN and VTA. 
Open-field test shows the effect of finasteride on motor behaviors in adolescent (A) and early developmental rats (B). **P < 0.01, *P < 0.05. It is shown that finasteride treatment at doses of 25 and 50 mg/kg significantly inhibits the motor behaviors in adolescent rats (A) in comparison with control group, while has no effect in early developmental rats (B). (n = 7 for each group) 
| Statistical analysis
Statistical analysis was carried out with SPSS 21.0. All data were presented as means ± SD. For data followed equal variance and normal distribution, 1-way ANOVA was applied followed with post hoc Tukey's HSD. For data not in accordance with equal variance or normal distribution, Kruskal-Wallis test was used followed by pairwise comparisons. P < 0.05 was considered to be significant.
| RESULT
| Open-field behaviors
In adolescent rats, finasteride treatment both at doses of 25 and 50 mg/kg significantly decreased the numbers of walking, sniffing, climbing and rearing (only in 50 mg/kg group) in exploratory behaviors ( Figure 2A ) and decreased the numbers of vertical and horizontal activities and total path length in motor behaviors ( Figure 3A) compared with control group. The decreasing percentage ranged from 31% to 68% in exploratory behaviors and from 33% to 66% in motor behaviors (Table 2 ). With greater doses of finasteride used in 25 and 50 mg/kg, exploratory and motor behaviors were inhibited more significantly (Table 2) , which indicated the dose dependency of the decrease in open-field behaviors to finasteride. The finasteride treatment at dose of 3 mg/kg had no effect on the open-field behaviors.
In early developmental rats, there was no significant change in exploratory and motor behaviors at any dose of finasteride or at any observation time point of postnatal day 21 or 49 compared with control group (Figures 2B and 3B ).
| Dopamine and its metabolites
In adolescent rats, finasteride treatment both at doses of 25 and 50 mg/kg significantly reduced the contents of dopamine in (Table 2) , which indicated the dose dependency of the decrease in contents to finasteride.
The levels of DOPAC and HVA in the frontal cortex and hippocampus were too low to be detected. The finasteride treatment at dose of 3 mg/kg had no effect on the contents of dopamine and its metabolites.
In early developmental rats, there was no significant change in the contents of dopamine, DOPAC and HVA at any dose of finasteride group or any observation time point of postnatal day 21 or 49 compared with control group (Figure 5 ).
| TH mRNA and protein expressions
In adolescent rats, finasteride treatment both at doses of 25 and 50 mg/kg significantly down-regulated TH expression both at mRNA and protein levels in SN and VTA ( Figure 6 ). With greater doses of finasteride used in 25 and 50 mg/kg, the expression of TH both at mRNA and protein levels were down-regulated more significantly (Table 2) , which indicated the dose dependency of the down-regulation of TH expressions to finasteride. The finasteride treatment at dose of 3 mg/kg had no effect on the TH expressions both at gene and protein
levels.
In early developmental rats, there was no significant change in TH expressions at either mRNA or protein level at any dose of finasteride group or any observation time point of postnatal day 21 or 49 compared with control group (Figure 7 ).
F I G U R E 4
Liquid chromatographymass spectrometry analysis shows the effect of finasteride on the contents of dopamine and its metabolites in adolescent rats. **P < 0.01, *P < 0. 
| DISCUSSION
The present study indicated that finasteride inhibited brain dopaminergic system and exploratory and motor behaviors in adolescent male rats. Dopaminergic system exerts important modulating effect on neuropsychiatric behaviors besides its regulation on motor control and learning new motor skills. 25 Many studies indicate that nigrostriatal dopamine pathway takes part in the drive of exploratory and locomotion behaviors. [26] [27] [28] [29] [30] For example, dopamine transporter inhibitor GBR-12909 and amphetamine increased open-field ambulation in rats 31 and preference for novel options in monkeys. 26 Furthermore, dopamine D4 receptor knockout mice showed reduced exploration in open-field test. 28 Therefore, it was suggested that the inhibition of exploratory and motor behaviors after finasteride treatment in the present study may be the result of, at least in part, the inhibition of dopaminergic system.
A series of studies suggest the involvement of dysfunction of dopaminergic system in the pathogenesis of neuropsychiatric disorders, such as Tourette syndrome and schizophrenia. 32, 33 For instance, hyperactivity and aberrant metabolisms of dopaminergic system, including high level of dopamine transporters, high densities of dopamine receptor D1 and D2 in frontal cortex, were found in the development and maintenance of Tourette syndrome.
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On the other hand, loss of dopamine in ventral striatum, amygdala, thalamus and cingulated cortex was shown to be associated with depression and anxiety in Parkinson disease. 34 Experimental F I G U R E 5 Liquid chromatography-mass spectrometry analysis shows the effect of finasteride on the contents of dopamine and its metabolites in early developmental rats. It is shown that finasteride treatment at any dose or any observing time point has no effect on the contents of dopamine (A-D) in frontal cortex, hippocampus, CPu and Acb and its metabolites including DOPAC (E-F) and HVA (G-H) in CPu and Acb compared to control group. Abbreviations used are the same to Figure 4 . (n = 7 for each group) studies revealed that decreased dopaminergic activity was associated with the reduction of exploratory and locomotor behaviors.
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Ablation of dopamine D2 receptor or age-related reduction of the brain dopaminergic activity was involved in motor dysfunction. 36, 37 Thus, the present finding that finasteride treatment inhibited brain dopaminergic system, implies finasteride as a potential therapeutic option for neuropsychiatric disorders with hyperactivities of dopaminergic system and androgen.
The present study demonstrated that administration of finasteride during adolescence inhibited dopaminergic system in late adolescent male rats. It was already revealed that testosterone levels in the plasma and testes elevate rapidly between postnatal day 20 and 30
F I G U R E 6
Real-time quantitative RT-PCR and western blot show the effect of finasteride on TH mRNA and protein expression, respectively, in adolescent rats. A and B are the relative expression of TH mRNA with the ratio of TH to GAPDH. In C and D, the upper panel is the immunoblot bands of TH and β-actin, and the lower panels are the relative expression of TH with the density ratio of immunoblot bands of TH to β-actin. **P < 0.01. It is shown that finasteride treatment at doses of 25 and 50 mg/kg significantly downregulated TH expression both at mRNA and protein levels in SN and VTA compared to control group. Abbreviations: TH, tyrosine hydroxylase; SN, substantia nigra; VTA, ventral tegmental area. (n = 7 for each group)
F I G U R E 7 Real-time quantitative RT-PCR and western blot show the effect of finasteride on TH mRNA and protein expression, respectively, in early developmental rats. A and B are the relative expression of TH mRNA with the ratio of TH to GAPDH. In C and D, the upper panel is the immunoblot bands of TH and β-actin, and the lower panels are the relative expression of TH with the density ratio of immunoblot bands of TH to β-actin. It is shown that finasteride treatment has no effect on the TH expression at any dose or any observing time point at gene or protein level compared to control group. Abbreviations used are the same to A recent study showed that administration of 3 mg/kg finasteride to young adult rats for 20 days failed to induce changes of dihydrotestosterone level in the cerebral spinal fluid and brain tissue. 39 In the present study, the same dose of finasteride treatment also did not elicit significant change in dopaminergic system or open-field behaviors in adolescent rats. Taken together, the present findings that finasteride treatment inhibited dopaminergic system only in adolescent rats rather than early developmental rats suggested that finasteride inhibited dopaminergic system by inhibiting the activity of androgen.
Androgen signaling is critical for central nervous system function, 40 and converging studies indicate the androgen stimulation on the activity of dopaminergic system. For example, administration of testosterone inhibited the reduction of dopamine and DOPAC in castrated male rats. 10 Castration decreased the activities of TH in caudate putamen, 41 and supplement with testosterone completely prevented castration-induced reduction in striatal TH activity. 41 Testosterone propionate treatment induced alterations in dopaminergic signaling pathway in the brain, [42] [43] [44] which increased the risk of mental illness.
42
These reports support the present conclusion that finasteride inhibited dopaminergic system by inhibiting the activity of androgen.
Although the present study suggested the effect of finasteride on dopaminergic system via the inhibition of androgen activity by comparing the effects of finasteride on adolescent and early developmental rats, one concern remains whether finasteride directly affects the dopaminergic system. Indeed, there is a report that rats at postnatal day 5-9 received 50 mg/kg finasteride decreased novelty-exploratory at adolescent age. 45 Thus, it cannot be denied that finasteride directly impacted brain dopaminergic system. More detailed studies are favorable to elucidate this concern. showed that 5α reductase II localized in the prefrontal cortex, basal ganglia, basolateral amygdala and hippocampus, 49 where the dopaminergic neurons or their projections are abundantly located, so finasteride is able to inhibit dihydrotestosterone production in these areas.
The above evidence provides neuroanatomical basis for the stimulation of androgen on dopaminergic system. Thus, in the present study, when finasteride was delivered to postnatal day 35 rats, dihydrotestosterone production was reduced. The stimulation of androgen binding with its receptor located on dopaminergic neurons in VTA and SN was decreased, which reduced dopamine production, and inhibited openfield behaviors.
In conclusion, the present study demonstrated that administra- 
